According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$17.95. In 2022 the company made an earnings per share (EPS) of -$11.92 an increase over its 2021 EPS that were of -$42.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$16.57 | 39.06% |
2022 | -$11.92 | -71.72% |
2021 | -$42.15 | -84.19% |
2020 | -$266.63 | -26.29% |
2019 | -$361.75 | 28.75% |
2018 | -$280.97 | 10.79% |
2017 | -$253.61 |